Illinois 2023-2024 Regular Session

Illinois House Bill HB5373

Introduced
2/9/24  
Introduced
2/9/24  
Refer
2/28/24  
Refer
2/9/24  
Report Pass
3/21/24  
Refer
2/28/24  
Engrossed
4/18/24  
Report Pass
3/21/24  
Refer
4/19/24  
Engrossed
4/18/24  
Refer
4/19/24  
Refer
11/6/24  

Caption

CONT SUB-CHRONIC PAIN TREATMEN

Impact

The implications of HB 5373 could be significant, as it aims to amend current state laws governing educational funding. The bill proposes a shift in how funds are allocated to school districts based on a variety of demographic and socioeconomic factors. This is likely to enhance the educational environment in underfunded areas and provide necessary resources to meet the diverse needs of students. Additionally, the adjustments could pave the way for increased state accountability in tracking the effective use of education funding.

Summary

House Bill 5373 focuses on enhancing funding mechanisms for public education within the state, particularly addressing the needs of underfunded school districts. This bill proposes adjustments to the existing funding formulas to ensure equitable distribution of financial resources, thereby giving districts with higher concentrations of low-income students and special education needs additional support. Advocates for the bill emphasize its importance in leveling the playing field in education quality across the state, aiming to provide each student with adequate opportunities regardless of their socioeconomic background.

Sentiment

General sentiment around HB 5373 has been largely positive among educators, parents, and advocacy groups focused on educational equity. Supporters argue that the bill addresses long-standing disparities within the state’s education system, thus fostering a more inclusive learning environment. However, there are concerns among some policymakers who fear the fiscal implications of increased funding commitments and the redistributive nature of the proposed changes, leading to tension in discussions around budget allocations.

Contention

Debate surrounding HB 5373 has highlighted several points of contention, particularly around the financial ramifications for wealthier districts as funds are redistributed to support those in greater need. Critics voice concerns that such strategies could disadvantage districts that already have stable funding systems in place. The bill also raises questions regarding the criteria used to determine funding levels, as some stakeholders argue that a one-size-fits-all approach may overlook unique local challenges.

Companion Bills

No companion bills found.

Previously Filed As

IL SB190

AN ACT relating to chronic pain treatments.

IL HB506

AN ACT relating to chronic pain treatments.

IL S03185

Provides outpatient insurance coverage for non-pharmacological treatments and non-opioid drugs for chronic pain.

IL A01921

Provides outpatient insurance coverage for non-pharmacological treatments and non-opioid drugs for chronic pain.

IL H0353

Sickle Cell Disease Treatment of Pain Continuing Education

IL S863

Relative to non-opioid options for chronic pain

IL SB3064

Relief of Chronic Pain Act of 2025

IL HB1318

renewing the committee to study non-pharmacological treatment options for patients with chronic pain.

IL SB5916

Concerning nonopioid drugs for the treatment of pain.

IL HB1034

Concerning nonopioid drugs for the treatment of pain.

Similar Bills

AZ HB2291

Opioids; containers; labeling; requirements; repeal

CA AB577

Health care coverage: antisteering.

RI H8318

Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.

RI S2889

Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.

HI HB2225

Relating To Health.

HI SB2751

Relating To Workers' Compensation.

RI H5866

Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.

RI S0795

Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.